Reading Your Progress Data

You’ve been tracking for a few weeks — maybe a couple of months. You’ve got a spreadsheet, an app, a notebook, something. Numbers are accumulating. And now you’re staring at those numbers wondering: am I on track?

Maybe you saw someone on Instagram post a 30-pound loss in two months and you’re sitting at eight. Maybe your weight went up two pounds this week after going down three the week before. Maybe you hit a stretch where nothing moved at all and you started spiraling through Reddit threads at 1am looking for reassurance.

Here’s the thing about data: it’s only useful if you know how to read it. And most people have never been taught how to interpret their own weight loss trajectory. They compare themselves to headlines, to social media, to clinical trial averages they’ve pulled out of context. That’s not reading data. That’s torturing yourself with data.

This page is about reading the whole story your numbers are telling — not just the page that happened to be open when you panicked.

---

Weight Loss Is Not a Straight Line

This is the single most important thing to understand about GLP-1 progress data, and almost nobody internalizes it the first time they hear it: weight loss is not linear.

It doesn’t go down in a smooth, steady slope. It goes down in stair-steps — a drop, a pause, a drop, a longer pause, a small drop. Some weeks it goes up. Then it drops again. Zoom out and the trend is clearly downward. Zoom in on any given week and it looks like chaos.

Clinical trial data backs this up. In the large-scale GLP-1 studies, the steepest weight loss happens between months 3 and 6. Then the rate starts flattening between months 6 and 9 — with the exact timing depending on where you started. A 2025 analysis by Horn and colleagues found that people who were overweight (but not obese) tended to reach their weight floor around 6 months, while people with Class II or Class III obesity took closer to 9 months before the curve leveled off.[1]

And then it levels off. The weight stabilizes. You hit what feels like a wall.

That wall is not failure. It’s a new equilibrium. Modeling work from the National Institutes of Health has shown that GLP-1 medications weaken your body’s appetite feedback system by roughly 40-50% — that’s why weight loss continues far longer than it does with traditional dieting, where your body fights back hard within weeks. But even with that advantage, your body eventually adapts to your new intake level and energy balance. The plateau is the medication working as expected, not the medication stopping.[2]

Here’s what matters most: in long-term trials, weight maintained at that plateau — no creep back up — for years. The SELECT trial followed people for four years on semaglutide. They lost weight, plateaued, and stayed there.[3] That plateau is the destination, not a pit stop on the way to regaining.

---

What "Good Progress" Actually Looks Like

One of the worst things you can do is compare your results to a single number from a clinical trial headline. Those numbers are averages across hundreds or thousands of people — they don’t tell you what any individual person experienced. But they are useful as a general map of what these medications can do.

Here’s what the major trials found:

Those are impressive numbers.[3][4][5] But there are important caveats.

If you have Type 2 diabetes, expect lower numbers — and that’s completely normal. People with diabetes consistently lose about 30-40% less weight than non-diabetic participants in the same trials. The SURPASS-2 trial, for example, showed substantial but smaller losses in people with Type 2 diabetes.[6] The reason is physiological, not motivational — insulin resistance and diabetes medications both affect how your body responds to weight loss interventions. Lower doesn’t mean wrong.

Real-world results are lower than trial results. In clinical trials, participants get regular check-ins, structured support, and close monitoring. In your actual life, you have work stress, holidays, missed doses, insurance gaps, and leftover pizza in the fridge. Real-world data consistently shows outcomes 20-40% lower than trial averages. But here’s the flip side: a Cleveland Clinic analysis found that patients who stayed adherent to their medication and followed up regularly approached trial-level results — losing between 11.9% and 18.0% of their body weight.[7]

That tells you something important: the gap between real-world and trial results isn’t about the medication being less effective outside of trials. It’s about the stuff that happens around the medication — adherence, support, engagement. Which is exactly why tracking matters.

---

The Health Thresholds That Actually Matter

When you’re fixated on a goal weight, it’s easy to miss how much has already changed. Here’s what the research says about clinically meaningful weight loss — the levels where your body starts seeing real health improvements:

1. 5% of body weight — Metabolic improvement begins. Blood pressure, blood sugar, cholesterol — all start shifting in a meaningful direction. If you weigh 250 pounds, that's 12.5 pounds. Not a headline number, but a real health outcome.[8]
2. 10% of body weight — The standard clinical goal for obesity treatment. Significant improvements in cardiovascular risk factors, joint pain, sleep apnea, and overall quality of life.
3. 15% or more — Cardiovascular event reduction and benefits for conditions like fatty liver disease. The SELECT trial showed a 20% reduction in major cardiac events at this level of loss.[3]

From my experience, most people set a goal weight based on what they think they should weigh — some number from their twenties, or a BMI chart, or what their doctor said five years ago. The clinical reality is that 10-15% of your starting weight delivers the vast majority of health benefits. You don’t need to lose half your body weight for this medication to have been worth it.

---

When the Scale Stalls but Your Body Doesn't

Here’s a scenario that drives people crazy: the scale hasn’t moved in three weeks, but your pants are looser. Your rings are spinning on your fingers. Your face looks different in photos.

That’s body recomposition — and it’s real.

The SURMOUNT-1 trial included DEXA scans (detailed body composition imaging) on a subset of participants — and the results tell a more encouraging story than the scale alone ever could.[9][3][10]

So if your waist circumference is shrinking, your measurements are changing, and the scale is stuck — that’s not a problem. That’s body recomposition doing exactly what you’d want it to do. The scale can’t tell the difference between a pound of fat and a pound of muscle. Your tape measure can.

---

When to Bring Your Data to Your Provider

Most progress patterns on GLP-1 medications are normal — including stalls, small fluctuations, and slower-than-expected loss. But there are specific patterns in your data worth flagging with your healthcare team:

One more thing worth knowing: late responders are real. Research suggests that roughly 18% of people don’t hit the 5% weight loss mark until around week 25 — that’s six months in. If you’re still in the early months, patience isn’t denial. It’s data-informed patience.[7]

---

The Social Media Comparison Trap

This one needs to be said plainly, because it’s doing real damage.

The GLP-1 content you see on social media is not a representative sample of real results. A 2025 analysis of GLP-1 medication content across major platforms found that roughly 80% of posts come from users who had notable results — classic survivorship bias. GI side effects were barely mentioned. And videos frequently showed a “high probability of AI modification” to before-and-after images.[11]

On TikTok specifically, 71% of videos about GLP-1 medications mentioned zero risks or side effects. Zero. That’s not a balanced perspective — that’s content optimized for engagement, not education.[11]

Here’s why this matters for reading your own data: when your reference point is a curated highlight reel, normal progress looks like failure. A steady, healthy 12% weight loss over six months is an excellent clinical outcome. But if you’re comparing it to someone’s 40-pound transformation video — which may have taken longer than claimed, been enhanced by editing, or come from someone with a very different starting point — your own data feels inadequate.

Research backs up the mental health angle too. A randomized controlled trial found that reducing social media use to less than 60 minutes per day improved body image and self-esteem in just three weeks.[12] Three weeks. If your tracking data is making you feel worse instead of better, the problem might not be your data — it might be what you’re comparing it to.

Your timeline is your timeline. Your starting point, your metabolism, your medication, your dose, your life circumstances — all of it is yours. The only comparison that matters is you versus your own baseline.

---

The Bottom Line

Data tells a story. But like any story, you have to read the whole thing — not just one page that happened to upset you.

Zoom out. Look at monthly trends, not daily numbers. Compare yourself to your own baseline three months ago, not to a stranger’s Instagram post. Understand that stair-steps, plateaus, and body recomposition are all part of the normal trajectory. Know what patterns warrant a provider conversation and which ones just need time.

And remember: the most important data point isn’t on any chart. It’s how you feel. Are you sleeping better? Moving easier? Thinking about food less? Fitting into clothes you’d given up on? Those are outcomes that matter — and no spreadsheet captures them perfectly.

Keep tracking. Keep reading the story. And give yourself credit for paying attention in the first place.

---